Side-by-side financials for FLGT and GH. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FLGT | GH |
|---|---|---|
| Market cap | - | $17.45 B |
| US-listed rank | - | #680 |
| Revenue (latest FY) | $322.67M | $982.02M |
| Net income (latest FY) | -$60.51M | -$416.30M |
| Net margin | -18.8% | -42.4% |
| SEC filings | 636 | 1,131 |
In their latest fiscal years, Fulgent Genetics, Inc. reported $322.67M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: Fulgent Genetics, Inc. and Guardant Health, Inc., or browse the full rankings.